Page last updated: 2024-08-22

olsalazine and Cancer of Pelvis

olsalazine has been researched along with Cancer of Pelvis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collins, RT; Deming, RL; Frank, AR; Hyland, G; Mailliard, JA; Martenson, JA; Moertel, CG; Moore, RL; Morton, RF; O'Fallon, JR; Tewfik, HH; Urias, RE1

Trials

1 trial(s) available for olsalazine and Cancer of Pelvis

ArticleYear
Olsalazine is contraindicated during pelvic radiation therapy: results of a double-blind, randomized clinical trial.
    International journal of radiation oncology, biology, physics, 1996, May-01, Volume: 35, Issue:2

    Topics: Aged; Aminosalicylic Acids; Contraindications; Defecation; Diarrhea; Double-Blind Method; Drug Administration Schedule; Female; Humans; Incidence; Male; Pelvic Neoplasms; Spasm

1996